4basebio

Bronze Sponsor

4basebio is enabling next generation cell and gene therapies and vaccines with its technologies and solutions. We are able to design, manufacture and supply application-specific synthetic DNA or mRNA as well as targeted non-viral vectors for the delivery of nucleic acid payloads. Our novel synthetic DNA technology offers unique customisation potential, rapid turn-around times, and improved safety profiles, addressing the current limitations of plasmids and other DNA technologies. We currently offer four DNA construct types, each ideally suited for use in viral and non-viral vector applications, genome editing, vaccines and therapeutics, and DNA vaccine applications, respectively. The material is available at GMP grade with significantly accelerated turnaround times as compared to plasmid DNA. Our proprietary non-viral delivery system, Hermes™, confers enhanced stability over conventional LNP platforms, and is suitable for a range of nucleic acid and biological payloads, including synthetic DNA. 

website